Understanding how COVID-19 affects medication treatment patterns in Medicare.
Rapid learning during a public health emergency: COVID-19 related medication treatment patterns in Medicare
This study looks at how doctors change the medications they prescribe for COVID-19 as new information comes out, especially for patients on Medicare, to help make sure everyone gets the best and safest treatments possible.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11077816 on NIH RePORTER |
What this research studies
This research investigates how new clinical evidence about COVID-19 treatments is integrated into medical practice, particularly focusing on Medicare patients. It aims to observe how physicians adopt or stop using certain medications based on evolving information about their effectiveness and safety. By analyzing prescription data and claims, the study seeks to identify patterns in medication use during the pandemic, which can inform future healthcare practices and policies. The goal is to improve patient safety and health outcomes while addressing issues of equity in access to effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are Medicare patients who have been prescribed medications related to COVID-19 treatment.
Not a fit: Patients who are not on Medicare or those who have not received medications for COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved medication practices that enhance patient safety and health outcomes during public health emergencies.
How similar studies have performed: Previous research has shown success in understanding medication practices during public health crises, making this approach both relevant and timely.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Karaca-Mandic, Pinar — University of Minnesota
- Study coordinator: Karaca-Mandic, Pinar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.